ArriVent BioPharma, Inc. (AVBP) free cash flow

Free cash flow · fiscal 2025
-$160.59M

ArriVent BioPharma, Inc. (AVBP) generated free cash flow of -$160.59M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$70.21M. Figures as of 18 Nov 2026, 12:21 UTC, from Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
-$160.59M
Highest on record
-$43.63Mfiscal 2022
Lowest on record
-$160.59Mfiscal 2025
Fiscal years on record
42022–2025

Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.

ArriVent BioPharma, Inc. free cash flow, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was -$43.63M in fiscal 2022 and the lowest -$160.59M in fiscal 2025.

History · 4 fiscal years

Free cash flow by fiscal year

ArriVent BioPharma, Inc. free cash flow, year by year

ArriVent BioPharma, Inc. (AVBP) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025-$160.59M—
2024-$70.21M—
2023-$55.84M—
2022-$43.63M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

More on AVBP

ArriVent BioPharma, Inc., figure by figure

ArriVent BioPharma, Inc. (AVBP) overview: price, valuation and scorecard

ArriVent BioPharma, Inc. free cash flow: questions and answers

What is ArriVent BioPharma, Inc.'s free cash flow?

ArriVent BioPharma, Inc. (AVBP) generated free cash flow of -$160.59M in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$70.21M.

What are the highest and lowest free cash flow figures on record for ArriVent BioPharma, Inc.?

Across the 4 fiscal years on record (2022–2025), the highest was -$43.63M in fiscal 2022 and the lowest -$160.59M in fiscal 2025.

How is ArriVent BioPharma, Inc.'s free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For ArriVent BioPharma, Inc. it is on record here for 4 fiscal years, 2022 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “ArriVent BioPharma, Inc. (AVBP) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/AVBP/free-cash-flow

Underlying data: Yahoo Finance.